Applied Materials Inc (AMAT)

56.40 -3.25  -5.45% NASDAQ Nov 21, 16:59 Delayed 2m USD

Applied Materials Research and Development Expense (Quarterly):

515.00M for Oct. 31, 2019
View 4,000+ financial data types
Browse...
View Full Chart

Research and Development Expense (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Research and Development Expense (Quarterly) Data

View and export this data going back to 1984. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Oct. 31, 2019 515.00M
July 31, 2019 515.00M
April 30, 2019 508.00M
Jan. 31, 2019 516.00M
Oct. 31, 2018 516.00M
July 31, 2018 505.00M
April 30, 2018 509.00M
Jan. 31, 2018 489.00M
Oct. 31, 2017 466.00M
July 31, 2017 454.00M
April 30, 2017 437.00M
Jan. 31, 2017 417.00M
Oct. 31, 2016 394.00M
July 31, 2016 386.00M
April 30, 2016 386.00M
Jan. 31, 2016 374.00M
Oct. 31, 2015 363.00M
July 31, 2015 372.00M
April 30, 2015 365.00M
Jan. 31, 2015 351.00M
Oct. 31, 2014 360.00M
July 31, 2014 357.00M
April 30, 2014 355.00M
Jan. 31, 2014 356.00M
Oct. 31, 2013 338.00M
   
July 31, 2013 334.00M
April 30, 2013 344.00M
Jan. 31, 2013 304.00M
Oct. 31, 2012 304.00M
July 31, 2012 309.00M
April 30, 2012 321.00M
Jan. 31, 2012 304.00M
Oct. 31, 2011 268.00M
July 31, 2011 282.00M
April 30, 2011 297.00M
Jan. 31, 2011 270.00M
Oct. 31, 2010 278.00M
July 31, 2010 290.00M
April 30, 2010 306.00M
Jan. 31, 2010 269.00M
Oct. 31, 2009 234.19M
July 31, 2009 234.05M
April 30, 2009 236.34M
Jan. 31, 2009 229.54M
Oct. 31, 2008 275.22M
July 31, 2008 268.56M
April 30, 2008 287.12M
Jan. 31, 2008 273.22M
Oct. 31, 2007 270.88M
July 31, 2007 292.58M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More

Advertisement

Research and Development Expense (Quarterly) Benchmarks

Benchmarks
Intel Corp 3.208B
Micron Technology Inc 623.00M
NVIDIA Corp 712.00M

Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 351.00M Jan 2015
Maximum 516.00M Oct 2018
Average 441.90M
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.